MACH7 TECHNOLOGIES LIMITED — Capital/Financing Update 2015

Oct 27, 2015

ASX Announcement

28 October 2015

==> picture [595 x 98] intentionally omitted <==

3D Medical raises $4M through oversubscribed placement

3D Medical Limited (ASX: 3DM ) ( 3DM or the Company ) is pleased to announce that it has successfully raised approximately $4 million through a placement of new shares to professional and sophisticated investors.

Wilson HTM acted as lead manager of the placement, which was oversubscribed. Under the placement, which was conducted within 3DM’s maximum existing placement capacity under Listing Rule 7.1, the Company will issue 53,121,066 new shares at $0.075 per share, raising a total of $3,984,080.

The new placement shares are expected to be issued on or around Friday 6 November 2015, and commence trading on ASX on the same day. The new shares will rank equally with all existing shares on issue from the date of allotment.

The placement is the first component of an equity capital raising of approximately $10 million, via a placement, a share purchase plan, which will enable existing shareholders to subscribe on the same terms as the placement, and through the exercise of existing options on issue in 3DM. These capital raising initiatives are undertaken as part of 3DM’s proposed merger with Mach7 Technologies Pte. Ltd. ( Mach7 ) through acquisition of 100% of the issued capital of Mach7. For further information on the proposed merger, refer to 3DM’s announcement and investor presentation dated 26 October 2015.

3DM’s Chairman Dr Nigel Finch said the Company was pleased with the level of interest shown in 3DM by professional and sophisticated investors.

“Our placement was oversubscribed. We are very pleased with the strong support from new and existing investors who have taken up shares in the placement. We see this as a strong endorsement of 3DM’s proposed merger with Mach7 and the expected benefits which will flow to all of our shareholders. On behalf of the Board, I welcome all new investors who participated in the placement to 3DM’s shareholder register.” Dr Finch said.

-ENDS

For more information, contact :

3D Medical Limited Dr Nigel Finch, Chairman (+61 421 742 878) Email: info@3Dmedical.com.au Web: www.3Dmedical.com.au

3D Medical Limited ACN 007 817 192 Unit 4, 435 Williamstown Road, Port Melbourne, Victoria 3207 W:www.3Dmedical.com.au I E:info@3Dmedical.com.au I T:+613 9646 2222 I F:+613 9645 4707

About 3D Medical Limited:

At 3D Medical our aim is to aid medical professionals in the facilitation of improved clinical care, improving medical procedures, diagnostics and ultimately improving patient outcomes.

3D Medical is a medical specific 3D printing and holographic projection and data integrations provider. Our services 3D Medical Printing; EchoPixel (holographic projection technology); GestSure (in surgery image control); Mach 7 (enterprise imaging solution provides healthcare organisations with the ability to archive, consolidate, access, and share medical imaging data across departments, locations and regions); and MediDATA provide medical practices the opportunity to leverage their analytical capabilities to gain an improved understanding of the characteristics of the patients which drive their business.

These new and innovative products leverage data already captured by conventional imaging modalities and apply it in more meaningful ways to deliver improved economic and patient outcomes.

Further information is available at www.3DMedical.com.au

About Mach7 Technologies:

Mach7 is a global provider of enterprise image management systems and services that allow healthcare enterprises to easily identify, connect, and share diagnostic image and patient care intelligence where and when it is needed. Their innovative communication and workflow technology delivers complete image management including rapid record identification, integration, synchronisation and routing, advanced clinical viewing, and optimized vendor neutral archiving (VNA) across the enterprise.

Healthcare institutions around the world use Mach7 solutions for archiving, clinical productivity improvement, IT cost savings, health information exchange, meaningful use compliance, and improved patient data communication. Mach7 has locations in the U.S., Asia, Australia, and the Middle East.

Further information is available at www.mach7t.com

3D Medical Limited ACN 007 817 192 Unit 4, 435 Williamstown Road, Port Melbourne, Victoria 3207 W:www.3Dmedical.com.au I E:info@3Dmedical.com.au I T:+613 9646 2222 I F:+613 9645 4707